Cargando…

The effects of Anisodamine-Tirofiban Combined Therapy in acute myocardial infarction treated with Percutaneous Coronary Intervention (PCI)

OBJECTIVES: To study the effects of anisodamine-tirofiban combined therapy on cardiac function and serological expression of serum NGF and ESM-1 in patients with acute myocardial infarction treated with percutaneous coronary intervention (PCI). METHODS: Eighty patients with myocardial infarction tre...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jiao, Yan, Fu, Xiaoying, Liu, Qingxin, Zhang, Wei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Professional Medical Publications 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9532679/ https://www.ncbi.nlm.nih.gov/pubmed/36246689 http://dx.doi.org/10.12669/pjms.38.7.5410

Ejemplares similares

Influence of Tirofiban maintenance duration on patients with acute myocardial infarction treated by percutaneous coronary intervention
por: Ji, Zhen-Guo, et al.
Publicado: (2015)

The Clinical Efficacy of Tirofiban Combined with Ticagrelor and Aspirin in Treating Acute Myocardial Infarction by Percutaneous Coronary Intervention and Its Effect on Patients' Cardiac Function
por: Peng, Rui, et al.
Publicado: (2022)

Influences of different dose of tirofiban for acute ST elevation myocardial infarction patients underwent percutaneous coronary intervention
por: Wang, Haixia, et al.
Publicado: (2020)

Analysis of the Best Timing for Applying Tirofiban in PCI Operation for the Patients with ST Segment Elevation Myocardial Infarction
por: Lei, Zhang, et al.
Publicado: (2015)

Impact of Hospital Volume of Percutaneous Coronary Intervention (PCI) on In-Hospital Outcomes in Patients with Acute Myocardial Infarction: Based on the 2014 Cohort of the Korean Percutaneous Coronary Intervention (K-PCI) Registry
por: Kim, Byong-Kyu, et al.
Publicado: (2020)

The Effects of Ticagrelor Combined with Tirofiban on Coagulation Function, Serum Myocardial Injury Markers, and Inflammatory Factor Levels in Patients with Acute Myocardial Infarction after Percutaneous Coronary Intervention
por: Li, Fang, et al.
Publicado: (2022)

Tirofiban hydrochloride sodium chloride injection combined with cardiovascular intervention in the treatment of Acute Myocardial Infarction
por: Liu, Yongxuan, et al.
Publicado: (2020)

Effects of tirofiban on stent thrombosis, Hs-CRP, IL-6 and sICAM-1 after PCI of acute myocardial infarction
por: Zhang, Yuqing, et al.
Publicado: (2018)

CVIT expert consensus document on primary percutaneous coronary intervention (PCI) for acute myocardial infarction (AMI) in 2018
por: Ozaki, Yukio, et al.
Publicado: (2018)

Tirofiban usage and prognosis after myocardial infarction
por: Eyüboğlu, Mehmet
Publicado: (2016)

Effect of Tirofiban Injection on vascular endothelial function, cardiac function and inflammatory cytokines in patients with acute myocardial infarction after emergency Percutaneous Coronary Intervention
por: Kang, Shi-xin, et al.
Publicado: (2022)

CVIT expert consensus document on primary percutaneous coronary intervention (PCI) for acute myocardial infarction (AMI) update 2022
por: Ozaki, Yukio, et al.
Publicado: (2022)

Intracoronary administration of tirofiban during percutaneous coronary intervention facilitates patients with acute coronary syndrome
por: Jia, Helei, et al.
Publicado: (2017)

Severe thrombocytopenia induced by tirofiban after percutaneous coronary intervention: a case report
por: Wang, Ze-Mu, et al.
Publicado: (2023)

Improved Cardiac Function and Attenuated Inflammatory Response by Additional Administration of Tirofiban during PCI for ST-Segment Elevation Myocardial Infarction Patients
por: Zhang, Jing, et al.
Publicado: (2021)

Effect of intra-coronary administration of tirofiban through aspiration catheter on patients over 60 years with ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention
por: Hu, Sigan, et al.
Publicado: (2018)

Application of tirofiban in patients with acute myocardial infarction complicated with diabetes and undergoing emergency interventional therapy
por: Tang, Xiuying, et al.
Publicado: (2022)

Effects of tirofiban on the reperfusion-related no-reflow in rats with acute myocardial infarction
por: Liu, Xiao, et al.
Publicado: (2013)

Tirofiban: A Rare Cause of Thrombocytopenia in a Patient Undergoing Percutaneous Coronary Intervention
por: Gulati, Amit, et al.
Publicado: (2021)

Impact of nodular calcification in patients with acute coronary syndrome (ACS) treated with primary percutaneous coronary intervention (PCI)
por: Demuyakor, Abigail, et al.
Publicado: (2022)

Effects of Intracoronary Pro-urokinase or Tirofiban on Coronary Flow During Primary Percutaneous Coronary Intervention for Acute Myocardial Infarction: A Multi-Center, Placebo-Controlled, Single-Blind, Randomized Clinical Trial
por: Huang, Dong, et al.
Publicado: (2021)

Depression and Anxiety after Acute Myocardial Infarction Treated by Primary PCI
por: Kala, Petr, et al.
Publicado: (2016)

Clinical efficacy and safety of tirofiban combined with conventional dual antiplatelet therapy in ACS patients undergoing PCI
por: Guo, Yong-zhe, et al.
Publicado: (2021)

HIV-Positive Patient With Non-Percutaneous Coronary Intervention (PCI)-Amenable Left Coronary Artery Aneurysms Presenting With ST-Elevation Myocardial Infarction (STEMI)
por: Khan, Raheel M, et al.
Publicado: (2023)

Role of tirofiban with dual antiplatelet therapy in patients with STEMI undergoing primary PCI
por: Türker, Yasin
Publicado: (2016)

Tirofiban shows better platelet inhibition in diabetic patients during PCI procedures
Publicado: (2010)

Effect of Operator Volume on In-Hospital Outcomes Following Primary Percutaneous Coronary Intervention for ST-Elevation Myocardial Infarction: Based on the 2014 Cohort of Korean Percutaneous Coronary Intervention (K-PCI) Registry
por: Lee, Jung-Hee, et al.
Publicado: (2019)

Syphilitic Coronary Artery Ostial Stenosis Resulting in Acute Myocardial Infarction Treated by Percutaneous Coronary Intervention
por: Nakazone, Marcelo A., et al.
Publicado: (2010)

Percutaneous coronary intervention for acute myocardial infarction with mitral regurgitation
por: Tu, Yan, et al.
Publicado: (2016)

Efficacy and safety of fondaparinux versus enoxaparin in patients undergoing percutaneous coronary intervention treated with the glycoprotein IIb/IIIa inhibitor tirofiban
por: Zhao, Xin, et al.
Publicado: (2016)

A comparison of long‐term clinical outcomes between percutaneous coronary intervention (PCI) and medical therapy in patients with chronic total occlusion in noninfarct‐related artery after PCI of acute myocardial infarction
por: Qin, Qing, et al.
Publicado: (2022)

Evaluating the role of intravenous pentoxifylline administration on primary percutaneous coronary intervention success rate in patients with ST-elevation myocardial infarction (PENTOS-PCI)
por: Kakavand, Hessam, et al.
Publicado: (2023)

Boosting platelet inhibition in poor responder to aspirin and clopidogrel undergoing percutaneous coronary intervention: role of tirofiban
por: Campo, Gianluca, et al.
Publicado: (2010)

Efficacy and safety of intracoronary versus intravenous tirofiban in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: A meta-analysis of randomized controlled trials
por: Tian, Rui, et al.
Publicado: (2023)

Effect of dapagliflozin on the prognosis of patients with acute myocardial infarction undergoing percutaneous coronary intervention
por: Zhu, Yi, et al.
Publicado: (2022)

Door-to-device time and mortality in patients with ST-elevation myocardial infarction treated with primary percutaneous coronary intervention: insight from real world data of Thai PCI Registry
por: Champasri, Kitcha, et al.
Publicado: (2023)

The effects of tirofiban infusion on clinical and angiographic outcomes of patients with STEMI undergoing primary PCI
por: Kaymaz, Cihangir, et al.
Publicado: (2016)

Comparison of myocardial microcirculatory perfusion after catheter‐administered intracoronary thrombolysis with anisodamine versus standard thrombus aspiration in patients with ST‐elevation myocardial infarction
por: Fu, Yang, et al.
Publicado: (2019)

Comparison of QT dispersion in patients with ST elevation acute myocardial infarction (STEMI) before and after treatment by streptokinase versus primary percutaneous coronary intervention (PCI)
por: Valizadeh, Abbas, et al.
Publicado: (2020)

Aspirin in combination with clopidogrel in the treatment of acute myocardial infarction patients undergoing percutaneous coronary intervention
por: Zhang, Xiaoyan, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_ojgcrt2nt5qslc0cqlv8gd1l1f